Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Category: Pharma applications

November 20, 2025 Drug delivery / Pharma applications

Carvone derived cannabidiol enantiomers as novel anticonvulsants

Developmental epilepsy syndromes are characterized by recurrent seizures and developmental delays. Current anticonvulsants target γ-aminobutyric acid type A receptor signaling

Continue reading

November 19, 2025 CD as API / Pharma applications

Amitriptyline in reducing bronchoconstriction effects compared to methyl BCD

Bronchial asthma is a chronic inflammatory disease with rising prevalence worldwide. Apart from the immunological role of the tricyclic antidepressant

Continue reading

November 18, 2025 Non-pharma applications / Pharma applications

Rotaxanes with integrated photoswitches: design principles, functional behavior, and emerging applications

Integrating molecular photoswitches into rotaxanes offers unique opportunities for precise control over their structural, dynamic, and functional properties. By harnessing

Continue reading

November 17, 2025 CD as API / Pharma applications

Cyclodextrins as Active Therapeutic Agents: Beyond Their Role as Excipients

Cyclodextrins (CDs) have traditionally been recognized as excipients that enhance solubility and stability of drugs. However, growing evidence shows that

Continue reading

November 13, 2025 Drug delivery / Food / Non-pharma applications / Pharma applications

Polyphenols’ encapsulation in cyclodextrins: An updated systematic literature review

Polyphenols are phytochemicals derived from fruits, leaves, flowers, roots, and other parts of various plants and other natural resources. These

Continue reading

November 12, 2025 CD as API / CD derivatives / Pharma applications

Methyl BCD-based supramolecular polyrotaxane as theranostic in anticancer immunotherapy

Despite the tremendous therapeutic promise of activating stimulators of interferon genes (STING) enable to prime robust de novo T-cell responses,

Continue reading

November 11, 2025 Drug delivery / Pharma applications

Cyclodextrin complexation of selected tyrosine kinase inhibitors

The comprehensive physicochemical characterization and cyclodextrin complexation of four tyrosine kinase inhibitors — erlotinib, gefitinib, vandetanib, and lapatinib — were

Continue reading

November 3, 2025 Drug delivery / Pharma applications

Cyclodextrin-in-Liposome for therapy: Advances and challenges

The concept of drug-in-cyclodextrin-in-liposomes (DCLs) was introduced to the scientific community thirty years ago by McCormack and Gregoriadis (1994). Since

Continue reading

October 31, 2025 Drug delivery / Pharma applications

Thymol/gallic acid/β-cyclodextrin bio-nanocomposite against quorum sensing system and biofilm formation in P. aeruginosa (PAO1)

The quorum sensing (QS) system and cell-to-cell communication have had a significant impact on biofilm formation and virulence factor increase

Continue reading

October 30, 2025 CD as API / CD derivatives / Pharma applications

Impact of Randomly Methylated Cyclodextrins on Candida albicans

The challenges related to biofilm-associated infections and diseases have prompted scientists to develop strategies aimed at reducing biofilm-forming capacity. Cells

Continue reading

Posts pagination

«Previous Posts 1 … 5 6 7 8 9 … 125 Next Posts»

Recent Posts

  • Surface-Engineered Amino-Graphene Oxide Aerogel Functionalized with Cyclodextrin for Desulfurization and Denitrogenation in Oil Refining
  • Cyclodextrin and KR12-Lipopeptide Interactions
  • Comparative study of thiolated and alkenylated functionalized β-CDs as highly mucopenetrating and mucoadhesive drug delivery systems.
  • Phosphorylated Beta-cyclodextrin as a New Bone-Targeting Drug Delivery System Could Change the Treatment of Osteoporosis and Other Bone Diseases
  • Arthur Lütringhaus, Godfather of catenanes was born 120 years ago

Tags

alpha-CD Alzheimer disease atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (26)
  • Analysis (63)
  • CD as API (339)
  • CD derivatives (395)
  • Cosmetics and toilettry (49)
  • Diagnosis (11)
  • Drug delivery (774)
  • E-ducation (63)
  • Environmental (129)
  • Events (232)
  • Food (217)
  • Gene delivery (19)
  • Household products (1)
  • Household products (4)
  • In Hungarian (4)
  • Life sciences (42)
  • Non-pharma applications (390)
  • Other industrial use (104)
  • Pharma applications (1,156)
  • Supramolecular systems (40)
  • Uncategorized (140)

Top Posts

  • Surface-Engineered Amino-Graphene Oxide Aerogel Functionalized with Cyclodextrin for Desulfurization and Denitrogenation in Oil Refining
  • HPαCD Therapy: A Breakthrough for Krabbe Disease Treatment
  • Cyclodextrin and KR12-Lipopeptide Interactions
  • Lanosterol eye drops for cataract treatment
  • Engineered Self-Assembly of Amphiphilic Cyclodextrin Conjugates for Drug Encapsulation
  • Phosphorylated Beta-cyclodextrin as a New Bone-Targeting Drug Delivery System Could Change the Treatment of Osteoporosis and Other Bone Diseases
  • Comparison of cholesterol complexation with β-cyclodextrin derivatives: A combined theoretical and experimental study
  • Gamma-cyclodextrin as molecular chaperone in protein delivery and stabilization
  • Simple method for detecting sulfite in wine and other beverages
  • Improved Bioavailability of Alpha-Lipoic Acid Through Cyclodextrin Complexation: A Potential for Enhanced Obesity Treatment

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 3,792 other subscribers
 

Loading Comments...